Joe DillonPresident at Dillon Capital Strategies
Joseph S. Dillon, Ph.D., MBA, is President & CEO of SynerPhysics, Inc. and President of Dillon Capital Strategies, the strategy and business analytics advisory arm of SynerPhysics.
Dr. Dillon is a seasoned pharmaceutical executive with over 30 years of experience. He has extensive experience in global pharmaceutical business development, planning and analysis, corporate finance, M&A, licensing, and technology valuations. Dr. Dillon has screened thousands of opportunities, valued over 400 deals and has been involved in over 45 closed transactions over the course of his career.
Since forming Dillon Capital Strategies, Dr. Dillon has consulted dozens of companies and held interim senior positions, including CEO and CFO at select clients. Dr. Dillon also provides specialized, strategic and transaction focused training for biopharma professionals.
Prior to this, Dr. Dillon held senior positions in pharmaceutical management consulting firms, most significantly as Senior Vice President, Head of Corporate Development Services and Valuations for The Mattson Jack Group/KantarHealth. Other previous positions include CEO, President, and Director of The Pharmaceutical Development Center (sold to AAI), a pharmaceutical developer and manufacturer; Executive Vice President and CFO of Vail Banks Inc., a multi-bank holding company (IPO, then sold to US Bancorp); CFO and Treasurer of Oread Inc., a contract pharmaceutical developer and manufacturer; and corporate positions with predecessor companies of Sanofi.
Dr. Dillon is Past-Chairperson of the Licensing Executive Society Life Sciences Sector. He is a veteran speaker at BIO, LES, WBR, EBD, and other prominent industry organization events. Dr. Dillon holds a Ph.D. in Metaphysical Sciences, an M.B.A. in International Finance and a bachelor’s degree in Finance.